Enhanced Recovery After Surgery in Extremity Sarcoma
NCT04461171 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2024-07-30
Summary
The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.
Conditions
- Sarcoma
Interventions
- PROCEDURE
-
Enhanced Recovery After Surgery
Undergo an enhanced recovery after surgery program
Sponsors & Collaborators
-
Joshua Lawrenz
lead OTHER
Principal Investigators
-
Joshua Lawrenz, MD · Vanderbilt Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-14
- Primary Completion
- 2025-12-31
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment
NCT04699214 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery
NCT00652860 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
NCT00544778 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
NCT03442465 ·Status: RECRUITING
-
Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma
NCT00004123 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
NCT00541411 ·Status: UNKNOWN ·Phase: NA
-
Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
NCT02812654 ·Status: UNKNOWN ·Phase: PHASE2
-
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
NCT01946529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Sarcoma
NCT00662233 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
NCT02657005 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
NCT06245746 ·Status: RECRUITING ·Phase: PHASE1
-
Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
NCT00002791 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery
NCT01958580 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
NCT00017160 ·Status: WITHDRAWN ·Phase: PHASE2
-
Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
NCT00004109 ·Status: COMPLETED ·Phase: PHASE1
-
ERAS Anesthetic Care for Metastatic Spine Cancer Resection
NCT05427825 ·Status: UNKNOWN ·Phase: NA
-
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
NCT01871766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
NCT00002516 ·Status: UNKNOWN ·Phase: PHASE3
-
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
NCT00002641 ·Status: COMPLETED ·Phase: PHASE3
-
Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
NCT05042934 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
NCT00003667 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma
NCT01969942 ·Status: WITHDRAWN ·Phase: PHASE1
-
Proton Beam Therapy for Chondrosarcoma
NCT00496522 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
NCT02249949 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
NCT00020566 ·Status: UNKNOWN ·Phase: PHASE3